Sarah Craus
Sarah Craus
Department of Medicine, Faculty of Medicine and Surgery, University of Malta, Mater Dei Hospital, Msida, Malta
Department of Medicine, Mater Dei Hospital, Msida, Malta
Search for other papers by Sarah Craus in
Google Scholar
PubMed
Department of Medicine, Mater Dei Hospital, Msida, Malta
Search for other papers by Sarah Craus in
Google Scholar
PubMed
Mark Gruppetta
Mark Gruppetta
Department of Medicine, Faculty of Medicine and Surgery, University of Malta, Mater Dei Hospital, Msida, Malta
Department of Medicine, Mater Dei Hospital, Msida, Malta
Search for other papers by Mark Gruppetta in
Google Scholar
PubMed
Department of Medicine, Mater Dei Hospital, Msida, Malta
Search for other papers by Mark Gruppetta in
Google Scholar
PubMed
Introduction Craniopharyngiomas are rare but challenging tumours. Despite being a serious condition, population-based epidemiological data on craniopharyngiomas are limited in other studies ( Bunin et al. 1998 , Haupt et al . 2006
Nele F Lenders
Nele F Lenders
Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Nele F Lenders in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Nele F Lenders in
Google Scholar
PubMed
Peter E Earls
Peter E Earls
Department of Anatomical Pathology and Cytopathology, St Vincent’s Pathology, Sydney, NSW, Australia
Search for other papers by Peter E Earls in
Google Scholar
PubMed
Search for other papers by Peter E Earls in
Google Scholar
PubMed
Warrick J Inder
Warrick J Inder
Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia
Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia
Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Faculty of Medicine, the University of Queensland, Brisbane, QLD, Australia
Search for other papers by Warrick J Inder in
Google Scholar
PubMed
Ann I McCormack
Ann I McCormack
Department of Endocrinology, St Vincent’s Hospital, Sydney, NSW, Australia
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Ann I McCormack in
Google Scholar
PubMed
Garvan Institute of Medical Research, Sydney, NSW, Australia
St Vincent’s Clinical School, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Ann I McCormack in
Google Scholar
PubMed
sella region such as craniopharyngiomas or meningiomas. The authors have chosen not to discuss the proposed nomenclature change from ‘pituitary adenoma’ to ‘PitNET’, as described in the WHO 2022 classification, as this is the subject of significant
Sandra Pekic
Sandra Pekic
School of Medicine, University of Belgrade, Belgrade, Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia
Search for other papers by Sandra Pekic in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia
Search for other papers by Sandra Pekic in
Google Scholar
PubMed
Marko Stojanovic
Marko Stojanovic
School of Medicine, University of Belgrade, Belgrade, Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia
Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia
Search for other papers by Marko Stojanovic in
Google Scholar
PubMed
Vera Popovic
Vera Popovic
School of Medicine, University of Belgrade, Belgrade, Serbia
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
, papillary craniopharyngioma and is identified in corticotroph adenomas ( Gualtieri et al. 2021 ). Mutations in BRAF have a high occurrence rate in different cancers. So the same underlying genetic driver has different unknown roles in different cell types
